Literature DB >> 25813565

Cell type specific changes in BMP-7 expression contribute to the progression of kidney disease in patients with obstructive uropathy.

Scott R Manson1, Joseph B Song1, Qiusha Guo1, Helen Liapis1, Paul F Austin1.   

Abstract

PURPOSE: Congenital urinary tract obstruction is a leading cause of renal maldevelopment and pediatric kidney disease. Nonetheless, few groups have examined its molecular pathogenesis in humans. We evaluated the role of BMP-7, a protein required for renal injury repair and nephrogenesis, in disease progression in patients with obstructive uropathy.
MATERIALS AND METHODS: Whole kidney and cell specific BMP-7 expression was examined in a murine model of unilateral ureteral obstruction and in patients with congenital ureteropelvic junction obstruction. Findings were correlated with molecular markers of renal injury and clinical parameters.
RESULTS: Unilateral ureteral obstruction led to a dramatic decrease in BMP-7 expression in the proximal and distal tubules before the onset of significant loss of renal architecture and fibrosis, suggesting that this is a critical molecular event that drives early stage disease progression. Loss of BMP-7 expression then extended to the collecting ducts and glomeruli in end stage kidney disease. When translating these findings to patients with ureteropelvic junction obstruction, global loss of BMP-7 expression correlated with a decreased number of nephrons, loss of renal architecture, severe renal fibrosis and loss of kidney function.
CONCLUSIONS: Given that BMP-7 has a critical role in renal injury repair and nephrogenesis, these findings show that cell specific changes in BMP-7 expression contribute to the onset of irreversible renal injury and impaired kidney development secondary to congenital urinary tract obstruction. Accordingly therapies that target these cell populations to restore BMP-7 activity may limit disease progression in patients with obstructive uropathy.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bone morphogenetic protein 7; fibrosis; growth and development; kidney; ureteral obstruction

Mesh:

Substances:

Year:  2015        PMID: 25813565      PMCID: PMC4502418          DOI: 10.1016/j.juro.2014.10.117

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  30 in total

1.  Localization of Tamm-Horsfall glycoprotein in the human kidney using immuno-fluorescence and immuno-electron microscopical techniques.

Authors:  K L Sikri; C L Foster; N MacHugh; R D Marshall
Journal:  J Anat       Date:  1981-06       Impact factor: 2.610

2.  Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function.

Authors:  Jeremiah Morrissey; Keith Hruska; Guangjie Guo; Song Wang; Qing Chen; Saulo Klahr
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

3.  Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

Authors:  K A Hruska; G Guo; M Wozniak; D Martin; S Miller; H Liapis; K Loveday; S Klahr; T K Sampath; J Morrissey
Journal:  Am J Physiol Renal Physiol       Date:  2000-07

4.  Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy.

Authors:  Shi-Nong Wang; Janine Lapage; Raimund Hirschberg
Journal:  J Am Soc Nephrol       Date:  2001-11       Impact factor: 10.121

5.  Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models.

Authors:  Michael Zeisberg; Cindy Bottiglio; Navin Kumar; Yohei Maeshima; Frank Strutz; Gerhard A Müller; Raghu Kalluri
Journal:  Am J Physiol Renal Physiol       Date:  2003-08-12

6.  Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy.

Authors:  Song Wang; Qing Chen; Theodore C Simon; Frank Strebeck; Lala Chaudhary; Jeremiah Morrissey; Helen Liapis; Saulo Klahr; Keith A Hruska
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

Review 7.  Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure.

Authors:  Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

Review 8.  Role of the TGF-β/BMP-7/Smad pathways in renal diseases.

Authors:  Xiao-Ming Meng; Arthur C K Chung; Hui Y Lan
Journal:  Clin Sci (Lond)       Date:  2013-02       Impact factor: 6.124

Review 9.  Obstructive uropathy: an important cause of chronic renal failure in children.

Authors:  Karl S Roth; Harry P Koo; Stephanie E Spottswood; James C M Chan
Journal:  Clin Pediatr (Phila)       Date:  2002-06       Impact factor: 1.168

10.  BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.

Authors:  Michael Zeisberg; Jun-ichi Hanai; Hikaru Sugimoto; Tadanori Mammoto; David Charytan; Frank Strutz; Raghu Kalluri
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

View more
  7 in total

1.  Structural analyses of von Willebrand factor C domains of collagen 2A and CCN3 reveal an alternative mode of binding to bone morphogenetic protein-2.

Authors:  Emma-Ruoqi Xu; Emily E Blythe; Gerhard Fischer; Marko Hyvönen
Journal:  J Biol Chem       Date:  2017-06-05       Impact factor: 5.157

2.  Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy.

Authors:  Adam C Midgley; Yongzhen Wei; Dashuai Zhu; Fangli Gao; Hongyu Yan; Anila Khalique; Wenya Luo; Huan Jiang; Xiangsheng Liu; Jiasen Guo; Chuangnian Zhang; Guowei Feng; Kai Wang; Xueyuan Bai; Wen Ning; Chao Yang; Qiang Zhao; Deling Kong
Journal:  J Am Soc Nephrol       Date:  2020-08-07       Impact factor: 10.121

3.  A porcine model of relief of unilateral ureteral obstruction: study on self-repairing capability over multiple time points.

Authors:  Yingying Liu; Jing Sun; Lining Miao; Lei Ji; Manyu Luo; Bing Li; Wenpeng Cui; Yangwei Wang; Yuansheng Xie; Xiangmei Chen
Journal:  Mol Cell Biochem       Date:  2016-07-06       Impact factor: 3.396

4.  Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification.

Authors:  Eva Gravesen; Maria Lerche Mace; Anders Nordholm; Jacob Hofman-Bang; Keith Hruska; Carsten Haagen Nielsen; Andreas Kjær; Klaus Olgaard; Ewa Lewin
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

5.  CCN2 reduction mediates protective effects of BMP7 treatment in obstructive nephropathy.

Authors:  Lucas L Falke; Jan Willem Leeuwis; Karen M Lyons; Christine L Mummery; Tri Q Nguyen; Roel Goldschmeding
Journal:  J Cell Commun Signal       Date:  2016-10-20       Impact factor: 5.782

6.  IL-15 Prevents Renal Fibrosis by Inhibiting Collagen Synthesis: A New Pathway in Chronic Kidney Disease?

Authors:  Aurore Devocelle; Lola Lecru; Sophie Ferlicot; Thomas Bessede; Jean-Jacques Candelier; Julien Giron-Michel; Hélène François
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

7.  BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease.

Authors:  Wei Peng; Xingcheng Zhou; Tingting Xu; Yanwen Mao; Xiaohuan Zhang; Huiming Liu; Luqun Liang; Lingling Liu; Lirong Liu; Ying Xiao; Fan Zhang; Shuang Li; Mingjun Shi; Yuxia Zhou; Lei Tang; Yuanyuan Wang; Bing Guo
Journal:  Cell Death Dis       Date:  2022-03-21       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.